Working to develop the scientific basis for a permanent regulatory framework for anthroposophic medicinal products in Europe

Evaluation of AM and AMPs as a whole system

Clinical studies

 

  1. Hamre HJ, Pham VN, Kern C, Rau R, Klasen J, Schendel U, Gerlach L, Drabik A, Simon L. A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs vs. conventional therapy including DMARDs for patients without preference. Patient Preference and Adherence 2018;12:375-97 https://doi.org/10.2147/PPA.S145221
  2. Hamre HJ, Glockmann A, Schwarz R, Riley DS, Baars EW, Kiene H, et al. Antibiotic use in children with acute respiratory or ear infections: prospective observational comparison of anthroposophic and conventional treatment under routine primary care conditions. Evid Based Complement Alternat Med 2014. https://doi.org/10.1155/2014/243801
  3. Hamre HJ, Kiene H, Ziegler R, Tröger W, Meinecke C, Schnürer C, et al. Overview of the publications from the Anthroposophic Medicine Outcomes Study (AMOS) - a whole system evaluation study. Global Adv Health Med 2014;3(1):54-70. https://doi.org/10.7453/gahmj.2013.010
  4. Hamre HJ, Kiene H, Glockmann A, Ziegler R, Kienle GS. Long-term outcomes of anthropo-sophic treatment for chronic disease: a four-year follow-up analysis of 1510 patients from a prospective observational study in routine outpatient settings. BMC Res Notes 2013;6(269). https://doi.org/10.1186/1756-0500-6-269
  5. Büssing A, Hirdes AT, Baumann K, Hvidt NC, Heusser P: Aspects of spirituality in medical doctors and their relation to specific views of illness and dealing with their patients' individual situation. Evid Based Complement Alternat Med 2013. https://doi.org/10.1155/2013/734392
  6. Hamre HJ, Witt CM, Kienle GS, Glockmann A, Willich SN, Kiene H. Predictors of outcome after 6 and 12 months following anthroposophic therapy for adult outpatients with chronic disease: a secondary analysis from a prospective observational study. BMC Res Notes 2010;3(218). https://doi.org/10.1186/1756-0500-3-218
  7. Hamre HJ, Witt CM, Kienle GS, Glockmann A, Ziegler R, Rivoir A, et al. Anthroposophic therapy for migraine: a two-year prospective cohort study in routine outpatient settings. Open Neurol J 2010;4:100-10. https://doi.org/10.2174/1874205X01004010100
  8. Hamre HJ, Witt CM, Kienle GS, Meinecke C, Glockmann A, Ziegler R, et al. Anthroposophic therapy for attention deficit hyperactivity: a two-year prospective study in outpatients. Int J Gen Med 2010;3:239-53. https://doi.org/10.2147/IJGM.S11725
  9. Hamre HJ, Witt CM, Kienle GS, Glockmann A, Ziegler R, Willich SN, Kiene H. Long-term out-comes of anthroposophic therapy for chronic low back pain: A two-year follow-up analysis. J Pain Res 2009;2:75-85. http://dx.doi.org/10.2147/JPR.S5922
  10. Hamre HJ, Witt CM, Kienle GS, Schnürer C, Glockmann A, Ziegler R, Willich SN, Kiene H. Anthroposophic therapy for asthma: a two-year prospective cohort study in routine outpatient settings. J Asthma Allergy 2009:2:111-128. http://dx.doi.org/10.2147/JAA.S7184
  11. Hamre HJ, Witt CM, Kienle GS, Glockmann A, Ziegler R, Willich SN, et al. Anthroposophic therapy for anxiety disorders: a two-year prospective cohort study in routine outpatient settings. Clin Med Psychiatr 2009;2:17-31. https://doi.org/10.4137/CMPsy.S2791
  12. Hamre HJ, Witt CM, Kienle GS, Meinecke C, Glockmann A, Willich SN, Kiene H. Anthroposophic therapy for children with chronic disease: a two-year prospective cohort study in routine outpatient settings. BMC Pediatr 2009, 9(39), https://doi.org/10.1186/1471-2431-9-39
  13. Hamre HJ, Witt CM, Glockmann A, Ziegler R, Kienle GS, Willich SN, et al. Outcome of anthroposophic medication therapy in chronic disease: A 12-month prospective cohort study. Drug Des Devel Ther 2008;2:25-37. http://www.ncbi.nlm.nih.gov/pubmed/19920891
  14. Hamre HJ, Witt CM, Glockmann A, Wegscheider K, Ziegler R, Willich SN et al. Anthroposophic vs. conventional therapy for chronic low back pain: a prospective comparative study. Eur J Med Res 2007; 12:302-310. https://www.ncbi.nlm.nih.gov/pubmed/17933703
  15. Hamre HJ, Witt CM, Glockmann A, Ziegler R, Willich SN, Kiene H. Anthroposophic therapy for chronic depression: a four-year prospective cohort study. BMC Psychiatry 2006(57), https://doi.org/10.1186/1471-244X-6-57
  16. Heusser P, Berger Braun S, Ziegler R, Bertschy M, Helwig S, van Wegberg B, Cerny T. Palliative in-patient cancer treatment in an anthroposophic hospital: I. Treatment patterns and compliance with anthroposophic medicine. Forsch Komplementärmed 2006;13:94-100. https://doi.org/10.1159/000091694
  17. Heusser P, Berger Braun S, Ziegler R, Bertschy M, Burkard R, Ziegler R, Helwig S, van Wegberg B, Cerny T. Palliative in-patient cancer treatment in an anthroposophic hospital: II. Quality of life during and after stationary treatment, and subjective treatment benefits. Forsch Komplementärmed 2006;13:156-66. https://doi.org/10.1159/000092448
  18. Hamre HJ, Fischer M, Heger M, Riley D, Haidvogl M, Baars E, et al. Anthroposophic vs. conventional therapy of acute respiratory and ear infections: a prospective outcomes study. Wien Klin Wochenschr 2005;117(7-8):256-68. https://doi.org/10.1007/s00508-005-0344-9

Systematic reviews
Clinical studies
Use, safety
Costs
Patient perspective and satisfaction